Tag: Biopharmaceutical company
Press release: Alvotech and STADA add to strategic alliance through denosumab partnership
Alvotech and STADA have expanded their strategic alliance by partnering on AVT03, a biosimilar to Prolia® and Xgeva® (denosumab) for the treatment of osteoporosis...